This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2003 Jun;126(Pt 6):1E; author reply 1E-a.

doi: 10.1093/brain/awg140.

Glatiramer acetate treatment in Devic's neuromyelitis optica

Roberto Bergamaschi

PMID: 12764069
DOI: 10.1093/brain/awg140

Case Reports

Glatiramer acetate treatment in Devic's neuromyelitis optica

Roberto Bergamaschi. Brain. 2003 Jun.

. 2003 Jun;126(Pt 6):1E; author reply 1E-a.

doi: 10.1093/brain/awg140.

Author

Roberto Bergamaschi

PMID: 12764069
DOI: 10.1093/brain/awg140

No abstract available

PubMed Disclaimer

Comment on

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.
Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. Lucchinetti CF, et al. Brain. 2002 Jul;125(Pt 7):1450-61. doi: 10.1093/brain/awf151. Brain. 2002. PMID: 12076996 Free PMC article.

Similar articles

Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Ayzenberg I, Schöllhammer J, Hoepner R, Hellwig K, Ringelstein M, Aktas O, Kümpfel T, Krumbholz M, Trebst C, Paul F, Pache F, Obermann M, Zeltner L, Schwab M, Berthele A, Jarius S, Kleiter I; Neuromyelitis Optica Study Group. Ayzenberg I, et al. J Neurol. 2016 Mar;263(3):575-82. doi: 10.1007/s00415-015-7991-1. Epub 2016 Jan 25. J Neurol. 2016. PMID: 26810718
A case of relapsing neuromyelitis optica treated with glatiramer acetate.
Bergamaschi R, Uggetti C, Tonietti S, Egitto MG, Cosi V. Bergamaschi R, et al. J Neurol. 2003 Mar;250(3):359-61. doi: 10.1007/s00415-003-0979-2. J Neurol. 2003. PMID: 12749321 No abstract available.
Relapsing neuromyelitis optica responsive to glatiramer acetate treatment.
Gartzen K, Limmroth V, Putzki N. Gartzen K, et al. Eur J Neurol. 2007 Jun;14(6):e12-3. doi: 10.1111/j.1468-1331.2007.01807.x. Eur J Neurol. 2007. PMID: 17539924 No abstract available.
Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM, Parks LP, Majithia V. Crout TM, et al. Curr Rheumatol Rep. 2016 Aug;18(8):54. doi: 10.1007/s11926-016-0599-3. Curr Rheumatol Rep. 2016. PMID: 27402111 Review.
Efficacy and tolerability of mitoxantrone for neuromyelitis optica spectrum disorder: A systematic review.
Enriquez CAG, Espiritu AI, Pasco PMD. Enriquez CAG, et al. J Neuroimmunol. 2019 Jul 15;332:126-134. doi: 10.1016/j.jneuroim.2019.04.007. Epub 2019 Apr 15. J Neuroimmunol. 2019. PMID: 31005713

See all similar articles

Cited by

Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS.
Häusler D, Hajiyeva Z, Traub JW, Zamvil SS, Lalive PH, Brück W, Weber MS. Häusler D, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 17;7(3):e698. doi: 10.1212/NXI.0000000000000698. Print 2020 May. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32184341 Free PMC article.
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Ayzenberg I, Schöllhammer J, Hoepner R, Hellwig K, Ringelstein M, Aktas O, Kümpfel T, Krumbholz M, Trebst C, Paul F, Pache F, Obermann M, Zeltner L, Schwab M, Berthele A, Jarius S, Kleiter I; Neuromyelitis Optica Study Group. Ayzenberg I, et al. J Neurol. 2016 Mar;263(3):575-82. doi: 10.1007/s00415-015-7991-1. Epub 2016 Jan 25. J Neurol. 2016. PMID: 26810718
Molecular pathogenesis of neuromyelitis optica.
Bukhari W, Barnett MH, Prain K, Broadley SA. Bukhari W, et al. Int J Mol Sci. 2012 Oct 11;13(10):12970-93. doi: 10.3390/ijms131012970. Int J Mol Sci. 2012. PMID: 23202933 Free PMC article. Review.
[Diagnosis and treatment of neuromyelitis optica. Consensus recommendations of the Neuromyelitis Optica Study Group].
Trebst C, Berthele A, Jarius S, Kümpfel T, Schippling S, Wildemann B, Wilke C; Neuromyelitis optica Studiengruppe (NEMOS). Trebst C, et al. Nervenarzt. 2011 Jun;82(6):768-77. doi: 10.1007/s00115-010-3192-4. Nervenarzt. 2011. PMID: 21174070 German. No abstract available.
[Neuromyelitis optica].
Jarius S, Wildemann B. Jarius S, et al. Nervenarzt. 2007 Dec;78(12):1365-77. doi: 10.1007/s00115-007-2262-8. Nervenarzt. 2007. PMID: 17934711 Review. German.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems